Mirae Asset Global ETFs Holdings’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-17,586
Closed -$25.5K – 3320
2026
Q1
$25.5K Buy
17,586
+402
+2% +$637 ﹤0.01% 3014
2025
Q4
$23.7K Buy
17,184
+460
+3% +$963 ﹤0.01% 3035
2025
Q3
$45.7K Sell
16,724
-3,036
-15% -$10.8K ﹤0.01% 2963
2025
Q2
$69K Buy
+19,760
New +$78K ﹤0.01% 2783

Other funds holding STIM

Mirae Asset Global ETFs Holdings's STIM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 17,586 shares — an estimated $25.5K sold.

Mirae Asset Global ETFs Holdings first reported a position in STIM in Q2 2025 and held it in 4 quarters. The position peaked at $69K in Q2 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 17,586 Neuronetics shares in Q2 2026, an estimated $25.5K.
  • Mirae Asset Global ETFs Holdings first reported a position in Neuronetics in Q2 2025 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Neuronetics position peaked at $69K in Q2 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.